NCT01810965View on ClinicalTrials.gov

Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 3, 2013

Primary Completion Date

April 19, 2019

Study Completion Date

April 19, 2019

Conditions
Hemochromatosis Type 1
Interventions
PROCEDURE

First evaluation phase : no intervention / Second evaluation phase: bloodletting of 7 ml/kg (with a maximum of 500ml)

Trial Locations (1)

35000

CHU Pontchaillou, Rennes

All Listed Sponsors
lead

Rennes University Hospital

OTHER

NCT01810965 - Impact of Bloodletting on Iron Metabolism in Type 1 Hemochromatosis | Biotech Hunter | Biotech Hunter